Latest News about GSK
Recent news which mentions GSK
   Moderna aims to prove it’s ‘more than a COVID company’
   
  
  
  September 13, 2023
  From MarketWatch
 
   FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
   
  
  
  September 12, 2023
  From Benzinga
 
   3 Pharmaceutical Stocks That Are Too Cheap to Ignore
   
  
  
  September 09, 2023
  From Motley Fool
 
   Vivek Ramaswamy's Parallels With Warren Buffett Run Deeper Than Wanting To Make Roivant The 'Berkshire Hathaway Of Drug Development'
   
  
  
  September 04, 2023
  From Benzinga
 
   7 Stocks Hedge Funds Are Loading Up On
   
  
  
  September 03, 2023
  From InvestorPlace
 
   3 Growth Stocks to Ride the Coming Bull Market in Style
   
  
  
  August 26, 2023
  From InvestorPlace
 
   3 Sorry Pharma Stocks to Sell in August Before It’s Too Late
   
  
  
  August 22, 2023
  From InvestorPlace
 From Benzinga
 
   Pfizer maternal RSV vaccine gets FDA approval
   
  
  
  August 21, 2023
  From MarketWatch
 Tickers 
   GSK
  
  
  From Motley Fool
 
   3 Pharma Stocks to Sell in August Before They Crash and Burn
   
  
  
  August 11, 2023
  From InvestorPlace
 
   GSK, Pfizer Lock Horns Over Patent Fight Related To Respiratory Syncytial Virus Vaccine
   
  
  
  August 02, 2023
  From Benzinga
 
   GSK's Jemperli Plus Chemo Combo Scores FDA Approval As First New Frontline Treatment For Certain Type Of Endometrial Cancer
   
  August 01, 2023
  Tickers 
   GSK
  
  
  From Benzinga
 From InvestorPlace
 From InvestorPlace
 
   Is GSK Stock Worth Buying Right Now?
   
  
  
  July 29, 2023
  From Motley Fool
 
   GSK Says 'Excellent' Q2 Performance Boosted By Vaccine & HIV Drug Sales, Raises 2023 Outlook
   
  July 26, 2023
  Tickers 
   GSK
  
  
  From Benzinga
 From Benzinga
 
   GSK-Pfizer Backed HIV-Focused Unit ViiV Healthcare's Cabotegravir Injected Drug, Tablets Secure European Backing For Approval
   
  
  
  July 24, 2023
  From Benzinga
 From InvestorPlace
 
   Why Shares of Vir Biotechnology Are Plunging Thursday
   
  
  
  July 20, 2023
  From Motley Fool
 
   Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
   
  
  
  July 13, 2023
  From Benzinga
 Tags
   NYSE:SE,NASDAQ:ALEC,NYSE:ASAN,NASDAQ:OKTA,NYSE:TWLO,NYSE:TDOC,NYSE:U,NYSE:GSK,NYSE:ABBV,NASDAQ:BIIB
   ASAN
   OKTA
  
  From InvestorPlace
 
   3 Healthcare Stocks With Healthy Dividends
   
  
  
  July 13, 2023
  From Motley Fool
 
   3 No-Brainer Stocks to Buy With $50 Right Now
   
  
  
  July 12, 2023
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
